Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis are chronic progressive immune-mediated rheumatic diseases (IMRD) that can cause a progressive disability and joint deformation and thus can impact in healthcare resource utilization (HCRU) and costs. The main outcome of the study...
Guardado en:
Autores principales: | Nuria Carballo, Enric Garcia-Alzórriz, Olivia Ferrández, María Eugenia Navarrete-Rouco, Xavier Durán-Jordà, Carolina Pérez-García, Jordi Monfort, Francesc Cots, Santiago Grau |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf24e1d4db94433b839a4a3136b664f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
por: Acar M, et al.
Publicado: (2018) -
SPONTANEOUS IMMUNOGLOBULIN-SYNTHESIZING ACTIVITY OF B LYMPHOCYTES IN INFLAMMATORY RHEUMATIC DISEASES
por: A.T. T. Mamasaidov, et al.
Publicado: (2014) -
Protocolo abreviado de resonancia magnética en espondiloartritis: más allá de la sacroileítis
por: Schiappacasse F,Giancarlo, et al.
Publicado: (2015) -
Remodelación ósea en espondiloartritis
por: Bautista-Molano,Wilson, et al.
Publicado: (2013) -
Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?
por: Amel Rezgui, et al.
Publicado: (2021)